Virtu KCG Holdings’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Virtu KCG Holdings’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-19,428	Closed	-$1.74M	–	3180
2016 Q2	$1.74M	Buy	19,428 +2,697	+16%	+$248K	0.04%	416
2016 Q1	$1.47M	Buy	+16,731	New	+$1.47M	0.04%	401
2015 Q4	–	Sell	-20,464	Closed	-$2.07M	–	3610
2015 Q3	$2.07M	Buy	+20,464	New	+$2.43M	0.03%	432
2014 Q4	–	Sell	-3,392	Closed	-$311K	–	3869
2014 Q3	$311K	Buy	+3,392	New	+$294K	0.01%	2322
2014 Q1	–	Sell	-5,954	Closed	-$412K	–	3664
2013 Q4	$412K	Buy	+5,954	New	+$391K	﹤0.01%	2187

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

JPCCM

J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return

MCWS

McKinley Carter Wealth Services Wheeling, West Virginia $1.73B AUM 17.28% 1-Year Est. Return

Virtu KCG Holdings's FBT Position: Q3 2016 in Review

Virtu KCG Holdings sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2016, closing a stake of 19,428 shares — an estimated $1.74M sold.

Virtu KCG Holdings first reported a position in FBT in Q4 2013 and held it in 5 quarters. The position peaked at $2.07M in Q3 2015. 111 funds tracked by Wall St. Rank hold FBT as of Q3 2016.

Virtu KCG Holdings reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2016 after selling out during the quarter.
Virtu KCG Holdings sold 19,428 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2016, an estimated $1.74M.
Virtu KCG Holdings first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2013 and held it in 5 quarters.
Virtu KCG Holdings's First Trust NYSE Arca Biotechnology Index Fund position peaked at $2.07M in Q3 2015.
111 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2016.

Based on Virtu KCG Holdings's 13F filing for Q3 2016, filed 10 Nov 2016.